PCH
IMNM icon

Polar Capital Holdings’s Immunome IMNM Stock Holding History

Polar Capital Holdings’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-849,479
Closed -$18.6M – 259
2026
Q1 		$18.6M Buy
849,479
+56,115
+7% +$1.25M 0.07% 149
2025
Q4 		$17M Sell
793,364
-265,412
-25% -$4.66M 0.07% 164
2025
Q3 		$12.4M Buy
1,058,776
+58,776
+6% +$585K 0.06% 190
2025
Q2 		$9.3M Buy
+1,000,000
New +$8.2M 0.05% 200

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Polar Capital Holdings's IMNM Position: Q2 2026 in Review

Polar Capital Holdings sold out of Immunome (IMNM) in Q2 2026, closing a stake of 849,479 shares — an estimated $18.6M sold.

Polar Capital Holdings first reported a position in IMNM in Q2 2025 and held it in 4 quarters. The position peaked at $18.6M in Q1 2026. 203 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Polar Capital Holdings reported no remaining Immunome position as of Q2 2026 after selling out during the quarter.
  • Polar Capital Holdings sold 849,479 Immunome shares in Q2 2026, an estimated $18.6M.
  • Polar Capital Holdings first reported a position in Immunome in Q2 2025 and held it in 4 quarters.
  • Polar Capital Holdings's Immunome position peaked at $18.6M in Q1 2026.
  • 203 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Polar Capital Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.